Incorporated in 2015 in Pune, India, SynThera began life as a 1 person start-up that was incubated at Entrepreneurship Development Center (better known as “NCL Venture Center”), India’s largest science business incubator. The initial focus of the Company was on glass-based biomaterial technologies and products for bone tissue regeneration therapies. These therapeutic products lie at the interface of biology, material science and engineering and are fundamentally reliant on synergy between knowledge between these different fields. Thus, the name “SynThera” was conceptualized as a combination of the words “SYNergy” and “THERApy”. The Company was, and still is, India’s first and only company focusing on glass-based biomaterials.
Today, SynThera is recognized both nationally and globally to be a pioneering company in this domain. Our patents and peer-reviewed journal articles demonstrate our technological prowess. We have won multiple awards and recognitions at city, state, national and international levels and have worked with multiple industrial and academic partners from across the world on various projects. We have expanded our product and technology portfolio within the bioactive glass domain, and we have forayed into entirely new areas such as antimicrobial glasses for long-term disinfection.
Leveraging our expertise in the development and production of high-purity glass materials for quality-intensive applications, we have also ventured into technical glass materials such as sealing, soldering and passivation glasses for use in industries such as electronics, aerospace, defence and lighting.
We are now striving to move further forward in our objective to become a globally renowned company in specialty glass products and technologies. We aim to achieve this by relentlessly focusing on the three pillars of quality, affordability and innovation in each and every product that we offer to our customers.